Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Remdesivir by Suzhou Vigonvita Life Sciences for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
Remdesivir is under clinical development by Suzhou Vigonvita Life Sciences and currently in Phase III for Coronavirus Disease 2019 (COVID-19)....